Skip to main content

Peer Review reports

From: Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review

Original Submission
15 Aug 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
20 Oct 2021 Reviewed Reviewer Report
24 Nov 2021 Reviewed Reviewer Report
14 Dec 2021 Author responded Author comments - Osama Soliman
Resubmission - Version 4
14 Dec 2021 Submitted Manuscript version 4
30 Dec 2021 Author responded Author comments - Osama Soliman
Resubmission - Version 5
30 Dec 2021 Submitted Manuscript version 5
8 Feb 2022 Reviewed Reviewer Report
27 Feb 2022 Author responded Author comments - Osama Soliman
Resubmission - Version 6
27 Feb 2022 Submitted Manuscript version 6
3 Mar 2022 Author responded Author comments - Osama Soliman
Resubmission - Version 7
3 Mar 2022 Submitted Manuscript version 7
7 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
16 Mar 2022 Editorially accepted
12 Apr 2022 Article published 10.1186/s12885-022-09437-z

You can find further information about peer review here.

Back to article page